Journal Mobile Options
Table of Contents
Vol. 51, No. 2, 2001
Issue release date: February 2001
Gynecol Obstet Invest 2001;51:128–133

Thermal Balloon Ablation in Myoma-Induced Menorrhagia under Local Anesthesia

Soysal M.E. · Soysal S.K. · Vicdan K.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: Our purposes were to compare the impact of surgery on menstrual blood flow reduction and on the increase in hemoglobin values as primary endpoints at 12 months, and operating time, complication rates, postoperative pain scores at 12 h and surgically induced amenorrhea rates at 12 months as secondary endpoints after roller ball endometrial ablation or thermal balloon ablation for myoma-induced menorrhagia. Materials and Methods: Menorrhagic women (documented by a validated pad scoring system) over 40 years of age, with a mobile myomatous uterus smaller than 12-week pregnancy, were enrolled in a prospective randomized trial to compare endometrial roller ball ablation and thermal balloon ablation after pharmacological endometrial thinning. One year after surgery, primary and secondary endpoints in both groups were compared. Results: Forty-five subjects underwent endometrial thermal balloon ablation under local anesthesia and 48 underwent endometrial roller ball ablation under general anesthesia. Statistically significant but similar decreases in mean pictorial blood assessment score and increases in mean hemoglobin values were noted for both groups at 12 months. Those who underwent endometrial roller ball ablation had experienced significantly more intraoperative complications. Conclusion: Thermal balloon ablation under local anesthesia for myoma-induced menor- rhagia provided both significant and statistically similar reductions in menstrual blood flow and increases in hemoglobin values with no intraoperative complication compared to roller ball endometrial ablation.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Hart R, Magos A: The alternatives to hysterectomy. Baillieres Clin Obstet Gynecol 1999;13:271–290.
  2. Baggish MS: Operative hysteroscopy; in Thompson ID, Rock JA (eds): Te Linde’s Operative Gynecology. ed 8. Philadelphia, Lippincott, 1997, pp 415–445.
  3. Vancaille TG: Electrocoagulation of the endometrium with the ball-end resectoscope. Obstet Gynecol 1989;74:425–427.
  4. Valle RF: Roller ball endometrial ablation. Baillières Clin Obstet Gynecol 1995;9:299–316.
  5. Neuwirth RS, Duran AA, Singer A, MacDonald R, Bolduc L: The endometrial ablator: A new instrument. Obstet Gynecol 1994;83:792–796.
  6. Lomano J: Endometrial ablation for the treatmant of menorrhagia: A comparison of patients with normal, enlarged, and fibroid uterus. Laser Surg Med 1991;11:8–12.
  7. Daniell JF: Endometrial ablation as an alternative to hysterectomy; in Diamond MP, Daniell JF, Jones HW (eds): Hysterectomy. Massachusetts, Blackwell, 1995, pp 167–181.
  8. Higham JM, O’Brien PMS, Shaw RW: Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734–739.
  9. Goldstein SR, Horii SC, Snyder JR, Raghacendra N, Subramanyam B: Estimation of nongravid uterine volume based on a normogram of gravid uterine volume: Its value in gynecologic uterine abnormalities. Obstet Gynecol 1988;72:86–90.
  10. Huskisson EJ: Measurement of pain. Lancet 1974;ii:1027–1031.
  11. Carlson KJ, Nichols DH, Schiff I: Indications for hysterectomy. N Engl J Med 1993;328:856–860.
  12. Carlson KJ, Miller BA, Fowler FJ: The Marine Women’s health study: I. Outcomes of hysterectomy. Obstet Gynecol 1994;83:556–565.
  13. Sculhper MJ, Dwyer N, Byford S, Stirrat GM: Randomized trial comparing hysterectomy and endometrial resection: Effect on health related quality of life and costs two years after surgery. Br J Obstet Gynaecol 1996;103:142–149.
  14. Pinion S, Parkin D, Abramovich D: Randomized trial of hysterectomy, endometrial laser ablation and transcervical endometrial resection for dysfunctional uterine bleeding. Br Med J 1994;309:979–983.
  15. O’Connor H, Magos A: Endometrial resection for the treatment of menorrhagia. N Engl J Med 1996;335:151–156.
  16. Magos AL, Baumann R, Lockwood GM, Turnbull AC: Experience with the first 250 endometrial resections for menorrhagia. Lancet 1991;337:1074–1078.
  17. Gannon MJ, Holt EM, Fairbank J, Fitzgerald M, Milne MA, Crystal AM: A randomised trial comparing endometrial resection and abdominal hysterectomy for the surgical treatment of menorrhagia. BMJ 1991;303:1362–1364.
  18. Landone A: Evaluation of surgical options in menorrhagia. Br J Obstet Gynaecol 1994;101 (suppl 11):8–14.
  19. Vilos GA, Pispidikis JT, Botz CK: Economic evaluation of hysteroscopic endometrial ablation versus vaginal hysterectomy for menorrhagia. Obstet Gynecol 1996;88:241–245.
  20. Overton C, Hargreaves J, Maresh M: A national survey of the complications of endometrial destruction for menstrual disorders: The MISTLETOE study. Br J Obstet Gynaecol 1997;104:1351–1359.
  21. Lumsden MA: Audit of transcervical endometrial ablation. Br J Obstet Gynaecol 1995;102:87–89.
  22. Goldenberg M, Zolti M, Seidman DS: Transient oxygen desaturation, hypercapnia and coagulopathy after operative hysteroscopy with glycine used as the distending medium. Am J Obstet Gynecol 1994;170:25.

    External Resources

  23. Arieff AI, Ayus AC: Endometrial ablation complicated by fatal hyponatremic encephalopathy. JAMA 1993;270:1230–1232.
  24. Broadbent JAM, Magos AL: Endometrial resection: Results and complications; in Lewis BV, Magos AL (eds): Endometrial Ablation. Edinburgh, Churchill Livingstone, 1993, pp 115–131.
  25. Iqbal PK, Paterson ME: Endometrial carcinoma after endometrial resection for menorrhagia. Br J Obstet Gynaecol 1997;104:1097–1098.
  26. Crosignani PG, Vercellini P, Apolone G, Giorgi OD, Cortesi I, Meschia M: Endometrial resection versus vaginal hysterectomy for menorrhagia: Long-term clinical and quality-of-life outcomes. Am J Obstet Gynecol 1997;177:95–101.
  27. Alexander DA, Naji AA, Pinion SB, Mollison J, Kitchener HC, Parkin DE: Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: Psychiatric and psychosocial aspects. BMJ 1996;312:280–284.
  28. Donnez J, Nisolle M, Clerckx F, Casanas-Roux P, Gillerot S: Advanced endoscopic techniques used in dysfunctional uterine bleeding, fibroids, and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment. Br J Obstet Gynaecol 1994;101:2–9.

    External Resources

  29. Singer A, Almanza R, Gutierrez A: Preliminary clinical experience with a thermal balloon endometrial ablation method to treat menorrhagia. Obstet Gynecol 1994;83:732–734.
  30. Vilos GA, Fortin CA, Sanders B, Pendley L, Stabinsky LA: Clinical trial of the uterine thermal balloon for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 1997;4:559–565.
  31. Amso NN, Stabinsky SA, Mc Faul P, Blanc B, Pendley L, Neuwirth R: Uterine thermal balloon therapy for the treatment of menorrhagia: The first 300 patients from a multi-centre study. Br J Obstet Gynaecol 1998;105:517–523.
  32. Friberg B, Joergensen C, Ahlgren M: Endometrial thermal coagulation – Degree of uterine fibrosis predicts treatment outcome. Gynecol Obstet Invest 1998;45:54–57.
  33. Meyer WR, Walsh BW, Grainger DA, Peacock LM, Loffer FD, Steege JF: Thermal balloon ablation and roller ball ablation to treat menorrhagia: A multicenter comparison. Obstet Gynecol 1998;92:98–103.
  34. Gervaise A, Fernandez H, Capella-Allouc S, Taylor S, Vieille SL, Hamou J, Gomel V: Thermal balloon ablation versus endometrial resection for the treatment of abnormal uterine bleeding. Hum Reprod 1999;14:2743–2747.
  35. Donnez J, Vilos G, Gannon MJ, Sorensen-Stampe S, Klinte I; Miller RM: Goserelin acetate plus endometrial ablation for dysfunctional uterine bleeding: A large randomized, double-blind study. Fertil Steril 1997;68:29–36.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50